These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 33369661

  • 1. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
    Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR.
    JAMA Netw Open; 2020 Dec 01; 3(12):e2031349. PubMed ID: 33369661
    [Abstract] [Full Text] [Related]

  • 2. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.
    Med Care; 2004 Mar 01; 42(3):239-50. PubMed ID: 15076823
    [Abstract] [Full Text] [Related]

  • 3. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
    Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.
    J Gen Intern Med; 2004 Feb 01; 19(2):146-55. PubMed ID: 15009794
    [Abstract] [Full Text] [Related]

  • 4. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K, Williams SB, Hu JC.
    JAMA Oncol; 2015 Apr 01; 1(1):60-7. PubMed ID: 26182305
    [Abstract] [Full Text] [Related]

  • 5. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD, Graves AJ, O'Neil B, Barocas DA, Chang SS, Penson DF, Resnick MJ.
    JAMA Surg; 2017 Jan 01; 152(1):27-34. PubMed ID: 27653425
    [Abstract] [Full Text] [Related]

  • 6. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
    Mahase SS, D'Angelo D, Kang J, Hu JC, Barbieri CE, Nagar H.
    JAMA Netw Open; 2020 Feb 05; 3(2):e1920471. PubMed ID: 32022878
    [Abstract] [Full Text] [Related]

  • 7. Racial Disparities in Active Surveillance for Prostate Cancer.
    Krishna S, Fan Y, Jarosek S, Adejoro O, Chamie K, Konety B.
    J Urol; 2017 Feb 05; 197(2):342-349. PubMed ID: 27596691
    [Abstract] [Full Text] [Related]

  • 8. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD.
    JAMA Intern Med; 2014 Sep 05; 174(9):1450-9. PubMed ID: 25023650
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
    Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W.
    Cancer; 2006 Mar 15; 106(6):1276-85. PubMed ID: 16475208
    [Abstract] [Full Text] [Related]

  • 11. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS, Stone BV, Roscoe C, Hsieh MC, Stroup AM, Wiggins CL, Schumacher FR, Gomez SL, Rebbeck TR, Trinh QD.
    JAMA Netw Open; 2024 Jun 03; 7(6):e2414582. PubMed ID: 38833252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.
    Filson CP, Schroeck FR, Ye Z, Wei JT, Hollenbeck BK, Miller DC.
    J Urol; 2014 Jul 03; 192(1):75-80. PubMed ID: 24518783
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C.
    JAMA Netw Open; 2020 Mar 02; 3(3):e201255. PubMed ID: 32191331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.